Home LiteratureArticle Details
PMID: 3500261 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

Regulation of cytolytic cell populations from human peripheral blood by B cell stimulatory factor 1 (interleukin 4).

The Journal of experimental medicine ·Vol. 166 ·No. 5 ·1987-11-01 ·Pages 1447-55

Widmer MB, Acres RB, Sassenfeld HM, Grabstein KH

Abstract

The effects of B cell stimulatory factor 1 (BSF-1) on the generation of human CTL and lymphokine-activated killer (LAK) cells in vitro were investigated. Both L-2 and BSF-1 were potent helper factors for the generation of antigen-specific CTL in MLC; detection of optimal BSF-1-induced CTL activity in this system occurred when BSF-1 was added to cultures after an initial period of activation during which exogenous BSF-1 was not present. In contrast to IL-2, BSF-1 failed to induce an LAK cell population, as detected with Daudi tumor targets, in cultures that had not been allosensitized. Furthermore, when both lymphokines were added together at culture initiation, BSF-1 inhibited the IL-2-driven generation of cytolytic cells. The differential ability of BSF-1 to promote the generation of CTL but not LAK could have important implications for lymphokine-mediated immunotherapy.

MeSH Terms
Cell Differentiation Cell Division Cells, Cultured Humans Interleukin-2/pharmacology Interleukin-4 Interleukins/pharmacology Killer Cells, Natural/cytology Lymphocyte Activation Lymphokines/pharmacology Recombinant Proteins/pharmacology T-Lymphocytes, Cytotoxic/cytology
Chemicals
Interleukin-2 Interleukins Lymphokines Recombinant Proteins Interleukin-4
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Widmer M B
Immunex Corporation, Seattle, Washington 98101.
Acres R B
Sassenfeld H M
Grabstein K H
References (23)
23 references, click to expand
  1. Regulation of murine T cell proliferation by B cell stimulatory factor-1.
    J Immunol. 1987 Aug 15;139(4):1148-53 PMID: 3112226
  2. Identification of cellular mechanisms operational in vivo during the regression of established pulmonary metastases by the systemic administration of high-dose recombinant interleukin 2.
    J Immunol. 1987 Jul 1;139(1):285-94 PMID: 3108401
  3. In vitro growth of murine T cells. V. The isolation and growth of lymphoid cells infiltrating syngeneic solid tumors.
    J Immunol. 1980 Jul;125(1):238-45 PMID: 6966652
  4. Identification of a T cell-derived b cell growth factor distinct from interleukin 2.
    J Exp Med. 1982 Mar 1;155(3):914-23 PMID: 6977612
  5. A differentiation factor required for the expression of cytotoxic T-cell function.
    Nature. 1982 Apr 22;296(5859):754-7 PMID: 6803172
  6. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
    J Exp Med. 1982 Jun 1;155(6):1823-41 PMID: 6176669
  7. Dissection of the proliferative and differentiative signals controlling murine cytotoxic T lymphocyte responses.
    J Exp Med. 1982 Jun 1;155(6):1876-81 PMID: 6978927
  8. Characterization of helper factors distinct from interleukin 2 necessary for the generation of allospecific cytolytic T lymphocytes.
    J Immunol. 1983 Feb;130(2):756-62 PMID: 6184404
  9. Generation of alloreactive cytotoxic T lymphocytes: evidence for a differentiation factor distinct from IL 2.
    J Immunol. 1983 Feb;130(2):763-7 PMID: 6600253
  10. Differential sensitivity of human B cell subsets to activation signals delivered by anti-mu antibody and proliferative signals delivered by a monoclonal B cell growth factor.
    J Exp Med. 1983 Feb 1;157(2):530-46 PMID: 6401797
  11. Induction of cytotoxic T cell function requires sequential action of three different lymphokines.
    J Immunol. 1983 Jun;130(6):2508-10 PMID: 6602167
  12. Three different signals are required for the induction of cytolytic T lymphocytes from resting precursors.
    J Immunol. 1983 Aug;131(2):606-10 PMID: 6602842
  13. Biological activity of recombinant human interleukin-2 produced in Escherichia coli.
    Science. 1984 Mar 30;223(4643):1412-4 PMID: 6367046
  14. Functional activity in vivo of effector T cell populations. II. Anti-tumor activity exhibited by syngeneic anti-MoMULV-specific cytolytic T cell clones.
    J Immunol. 1984 Sep;133(3):1664-70 PMID: 6205090
  15. Lymphokine purification by reversed-phase high-performance liquid chromatography.
    J Chromatogr. 1984 Jul 27;296:171-9 PMID: 6332819
  16. Interleukin 2 is both necessary and sufficient for the growth and differentiation of lectin-stimulated cytolytic T lymphocyte precursors.
    J Immunol. 1985 Mar;134(3):1644-52 PMID: 3871453
  17. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer.
    N Engl J Med. 1985 Dec 5;313(23):1485-92 PMID: 3903508
  18. Destruction of autologous human lymphocytes by interleukin 2-activated cytotoxic cells.
    J Immunol. 1986 Jul 15;137(2):502-11 PMID: 2424971
  19. B cell-stimulatory factor 1 (BSF-1) promotes growth of helper T cell lines.
    J Exp Med. 1986 Aug 1;164(2):580-93 PMID: 2941517
  20. Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell- and T-cell-stimulating activities.
    Proc Natl Acad Sci U S A. 1986 Aug;83(16):5894-8 PMID: 3016727
  21. B cell stimulatory factor 1 (interleukin 4) is a potent costimulant for normal resting T lymphocytes.
    J Exp Med. 1987 Jan 1;165(1):157-72 PMID: 3098893
  22. Regulation of cytolytic T-lymphocyte generation by B-cell stimulatory factor.
    Nature. 1987 Apr 23-29;326(6115):795-8 PMID: 3494950
  23. Production of IL-1 alpha and IL-1 beta by clones of EBV transformed, human B cells.
    Mol Immunol. 1987 May;24(5):479-85 PMID: 2821386
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1987-11-01
Pages
1447-55
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2189660
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]